Eloxx Pharmaceuticals, Inc.
SEC Filing List
ELOX CIK: 0001035354
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Kjellson Nina S | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/10/2026 | |
| 4 | Statement of changes in beneficial owner... | Webster Stephen W | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/10/2026 | |
| 4 | Statement of changes in beneficial owner... | Walts Alan Edmund | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/10/2026 | |
| 4 | Statement of changes in beneficial owner... | Aggarwal Sumit | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/10/2026 | |
| 4 | Statement of changes in beneficial owner... | Rubin Steven D | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/10/2026 | |
| 424B4 | Prospectus filed pursuant to Rule 424(b)(4) | Eloxx Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/09/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 06/08/2026 | ||
| CERT | Certification by an exchange approving s... | Eloxx Pharmaceuticals, Inc. | 06/08/2026 | ||
| 4 | Statement of changes in beneficial owner... | Domicilium Real Estate Fund Iii Lp | SEWARD & KISSEL LLP /fa | 06/05/2026 | |
| SCHEDULE 13G/A | SEWARD & KISSEL LLP /fa | 06/05/2026 | |||
| No record found. | |||||
| Load More | |||||
